Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Applied DNA Sciences Inc (NASDAQ:APDN)

1.75
Delayed Data
As of Apr 28
 0.00 / 0.00%
Today’s Change
1.40
Today|||52-Week Range
3.61
-5.41%
Year-to-Date
No recent news for Applied DNA Sciences Inc.

Today’s Trading

Previous close1.75
Today’s open1.80
Day’s range1.66 - 1.86
Volume129,015
Average volume (3 months)67,464
Market cap$46.1M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+19.05%
Earnings growth (this year)+31.37%
Earnings growth (next 5 years)--
Revenue growth (last year)-53.53%
P/E ratioNM
Price/Sales17.26
Price/Book4.07

Competitors

 Today’s
change
Today’s
% change
EBIOEleven Biotherapeuti...-0.02-1.04%
BLPHBellerophon Therapeu...-0.07-4.61%
PULMPulmatrix Inc-0.07-2.47%
JNPJuniper Pharmaceutic...+0.20+4.55%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$4.2M
Annual profit (last year)-$12.2M
Net profit margin-290.84%

Profile

Sector
Technology Services
Industry
Information Technology Services
Chairman, President &
Chief Executive Officer
James A. Hayward
Chief Financial Officer &
Controller
Beth Jantzen
Corporate headquarters
Stony Brook, New York

Forecasts